PTC Therapeutics, Inc. (PTCT)
71.79
+1.23
(+1.74%)
USD |
NASDAQ |
Sep 02, 16:00
71.78
-0.01
(-0.01%)
After-Hours: 20:00
PTC Therapeutics Cash from Investing (Quarterly) : -122.56M for June 30, 2026
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -122.56M |
| March 31, 2026 | -93.74M |
| December 31, 2025 | 34.01M |
| September 30, 2025 | -289.62M |
| June 30, 2025 | -422.01M |
| March 31, 2025 | -184.36M |
| December 31, 2024 | 267.71M |
| September 30, 2024 | -42.68M |
| June 30, 2024 | -65.92M |
| March 31, 2024 | -114.93M |
| December 31, 2023 | -94.42M |
| September 30, 2023 | -47.76M |
| June 30, 2023 | -5.593M |
| March 31, 2023 | -28.97M |
| December 31, 2022 | 32.44M |
| September 30, 2022 | 136.44M |
| June 30, 2022 | 72.25M |
| March 31, 2022 | 49.04M |
| December 31, 2021 | 68.27M |
| September 30, 2021 | 64.70M |
| June 30, 2021 | 56.06M |
| March 31, 2021 | 30.15M |
| December 31, 2020 | -208.12M |
| September 30, 2020 | -394.21M |
| June 30, 2020 | 142.06M |
| Date | Value |
|---|---|
| March 31, 2020 | -101.27M |
| December 31, 2019 | -229.00M |
| September 30, 2019 | 30.43M |
| June 30, 2019 | -38.17M |
| March 31, 2019 | -150.50M |
| December 31, 2018 | -24.60M |
| September 30, 2018 | -24.11M |
| June 30, 2018 | 7.744M |
| March 31, 2018 | -1.648M |
| December 31, 2017 | -54.04M |
| September 30, 2017 | 19.27M |
| June 30, 2017 | 23.47M |
| March 31, 2017 | 24.42M |
| December 31, 2016 | 23.13M |
| September 30, 2016 | 38.24M |
| June 30, 2016 | 21.00M |
| March 31, 2016 | 22.12M |
| December 31, 2015 | -51.83M |
| September 30, 2015 | -6.284M |
| June 30, 2015 | 16.70M |
| March 31, 2015 | 20.61M |
| December 31, 2014 | -113.18M |
| September 30, 2014 | 48.38M |
| June 30, 2014 | -76.09M |
| March 31, 2014 | -4.267M |
Cash From Investing Definition
Represents the net cash flow from the company's investing activities. Investing activities represent the movement in the company's long-term assets.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Biogen, Inc. | -3.839B |
| BioMarin Pharmaceutical, Inc. | -5.102B |
| Arcturus Therapeutics Holdings, Inc. | 0.0193M |
| Spruce Biosciences, Inc. | -0.135M |
| ACADIA Pharmaceuticals, Inc. | -8.529M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 129.11M |
| Cash from Financing (Quarterly) | 211.88M |
| Free Cash Flow | -332.49M |
| Free Cash Flow Per Share (Quarterly) | 1.326 |
| Free Cash Flow to Equity (Quarterly) | -179.41M |
| Free Cash Flow to Firm (Quarterly) | 163.47M |
| Free Cash Flow Yield | -5.41% |